Selected research
Industry Research
Diclazuril Industry Research Report 2026
Market perspective
The global Diclazuril market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diclazuril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diclazuril is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diclazuril is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diclazuril include Zhongmu Lide Pharm, Zhengmu Technology, Zhengyu Pharm, Tianjin Shengji, Tianhe Biology, SMAPC, Huifeng Pharm, Huangkang Animal Pharm and Shenlong Animal Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diclazuril market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diclazuril Market by Company
Zhongmu Lide Pharm
Zhengmu Technology
Zhengyu Pharm
Tianjin Shengji
Tianhe Biology
SMAPC
Huifeng Pharm
Huangkang Animal Pharm
Shenlong Animal Pharm
Da Hua Nong
Da Bei Nong
Bayer
Bamu Technology
Kepro
Huve Pharma
Biovet
Diclazuril Segment by Type
99% Purity Type
98% Purity Type
95% Purity Type
Others
Diclazuril Segment by Application
Diclazuril Premix
Diclazuril Solution
Diclazuril Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diclazuril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diclazuril and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diclazuril.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diclazuril manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diclazuril by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diclazuril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 99% Purity Type
- 98% Purity Type
- 95% Purity Type
- Others
Applications
- Diclazuril Premix
- Diclazuril Solution
Companies covered
- Zhongmu Lide Pharm
- Zhengmu Technology
- Zhengyu Pharm
- Tianjin Shengji
- Tianhe Biology
- SMAPC
- Huifeng Pharm
- Huangkang Animal Pharm
- Shenlong Animal Pharm
- Da Hua Nong
- Da Bei Nong
- Bayer
- Bamu Technology
- Kepro
- Huve Pharma
- Biovet
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diclazuril Market Size (2021-2032)
- 2.2.2 Global Diclazuril Sales (2021-2032)
- 2.2.3 Global Diclazuril Market Average Price (2021-2032)
- 2.3 Diclazuril by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 99% Purity Type
- 2.3.3 98% Purity Type
- 2.3.4 95% Purity Type
- 2.3.5 Others
- 2.4 Diclazuril by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Diclazuril Premix
- 2.4.3 Diclazuril Solution
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diclazuril Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diclazuril Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Diclazuril Revenue of Manufacturers (2021-2026)
- 3.4 Global Diclazuril Average Price by Manufacturers (2021-2026)
- 3.5 Global Diclazuril Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diclazuril, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diclazuril, Product Type & Application
- 3.8 Global Manufacturers of Diclazuril, Established Date
- 3.9 Global Diclazuril Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhongmu Lide Pharm
- 4.1.1 Zhongmu Lide Pharm Company Information
- 4.1.2 Zhongmu Lide Pharm Business Overview
- 4.1.3 Zhongmu Lide Pharm Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhongmu Lide Pharm Diclazuril Product Portfolio
- 4.1.5 Zhongmu Lide Pharm Recent Developments
- 4.2 Zhengmu Technology
- 4.2.1 Zhengmu Technology Company Information
- 4.2.2 Zhengmu Technology Business Overview
- 4.2.3 Zhengmu Technology Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhengmu Technology Diclazuril Product Portfolio
- 4.2.5 Zhengmu Technology Recent Developments
- 4.3 Zhengyu Pharm
- 4.3.1 Zhengyu Pharm Company Information
- 4.3.2 Zhengyu Pharm Business Overview
- 4.3.3 Zhengyu Pharm Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Zhengyu Pharm Diclazuril Product Portfolio
- 4.3.5 Zhengyu Pharm Recent Developments
- 4.4 Tianjin Shengji
- 4.4.1 Tianjin Shengji Company Information
- 4.4.2 Tianjin Shengji Business Overview
- 4.4.3 Tianjin Shengji Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tianjin Shengji Diclazuril Product Portfolio
- 4.4.5 Tianjin Shengji Recent Developments
- 4.5 Tianhe Biology
- 4.5.1 Tianhe Biology Company Information
- 4.5.2 Tianhe Biology Business Overview
- 4.5.3 Tianhe Biology Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tianhe Biology Diclazuril Product Portfolio
- 4.5.5 Tianhe Biology Recent Developments
- 4.6 SMAPC
- 4.6.1 SMAPC Company Information
- 4.6.2 SMAPC Business Overview
- 4.6.3 SMAPC Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SMAPC Diclazuril Product Portfolio
- 4.6.5 SMAPC Recent Developments
- 4.7 Huifeng Pharm
- 4.7.1 Huifeng Pharm Company Information
- 4.7.2 Huifeng Pharm Business Overview
- 4.7.3 Huifeng Pharm Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Huifeng Pharm Diclazuril Product Portfolio
- 4.7.5 Huifeng Pharm Recent Developments
- 4.8 Huangkang Animal Pharm
- 4.8.1 Huangkang Animal Pharm Company Information
- 4.8.2 Huangkang Animal Pharm Business Overview
- 4.8.3 Huangkang Animal Pharm Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Huangkang Animal Pharm Diclazuril Product Portfolio
- 4.8.5 Huangkang Animal Pharm Recent Developments
- 4.9 Shenlong Animal Pharm
- 4.9.1 Shenlong Animal Pharm Company Information
- 4.9.2 Shenlong Animal Pharm Business Overview
- 4.9.3 Shenlong Animal Pharm Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shenlong Animal Pharm Diclazuril Product Portfolio
- 4.9.5 Shenlong Animal Pharm Recent Developments
- 4.10 Da Hua Nong
- 4.10.1 Da Hua Nong Company Information
- 4.10.2 Da Hua Nong Business Overview
- 4.10.3 Da Hua Nong Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Da Hua Nong Diclazuril Product Portfolio
- 4.10.5 Da Hua Nong Recent Developments
- 4.11 Da Bei Nong
- 4.11.1 Da Bei Nong Company Information
- 4.11.2 Da Bei Nong Business Overview
- 4.11.3 Da Bei Nong Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Da Bei Nong Diclazuril Product Portfolio
- 4.11.5 Da Bei Nong Recent Developments
- 4.12 Bayer
- 4.12.1 Bayer Company Information
- 4.12.2 Bayer Business Overview
- 4.12.3 Bayer Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bayer Diclazuril Product Portfolio
- 4.12.5 Bayer Recent Developments
- 4.13 Bamu Technology
- 4.13.1 Bamu Technology Company Information
- 4.13.2 Bamu Technology Business Overview
- 4.13.3 Bamu Technology Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bamu Technology Diclazuril Product Portfolio
- 4.13.5 Bamu Technology Recent Developments
- 4.14 Kepro
- 4.14.1 Kepro Company Information
- 4.14.2 Kepro Business Overview
- 4.14.3 Kepro Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Kepro Diclazuril Product Portfolio
- 4.14.5 Kepro Recent Developments
- 4.15 Huve Pharma
- 4.15.1 Huve Pharma Company Information
- 4.15.2 Huve Pharma Business Overview
- 4.15.3 Huve Pharma Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Huve Pharma Diclazuril Product Portfolio
- 4.15.5 Huve Pharma Recent Developments
- 4.16 Biovet
- 4.16.1 Biovet Company Information
- 4.16.2 Biovet Business Overview
- 4.16.3 Biovet Diclazuril Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Biovet Diclazuril Product Portfolio
- 4.16.5 Biovet Recent Developments
5 Global Diclazuril Market Scenario by Region
- 5.1 Global Diclazuril Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diclazuril Sales by Region: 2021-2032
- 5.2.1 Global Diclazuril Sales by Region: 2021-2026
- 5.2.2 Global Diclazuril Sales by Region: 2027-2032
- 5.3 Global Diclazuril Revenue by Region: 2021-2032
- 5.3.1 Global Diclazuril Revenue by Region: 2021-2026
- 5.3.2 Global Diclazuril Revenue by Region: 2027-2032
- 5.4 North America Diclazuril Market Facts & Figures by Country
- 5.4.1 North America Diclazuril Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diclazuril Sales by Country (2021-2032)
- 5.4.3 North America Diclazuril Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diclazuril Market Facts & Figures by Country
- 5.5.1 Europe Diclazuril Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diclazuril Sales by Country (2021-2032)
- 5.5.3 Europe Diclazuril Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diclazuril Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diclazuril Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diclazuril Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diclazuril Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diclazuril Market Facts & Figures by Country
- 5.7.1 South America Diclazuril Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diclazuril Sales by Country (2021-2032)
- 5.7.3 South America Diclazuril Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Diclazuril Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diclazuril Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diclazuril Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diclazuril Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diclazuril Sales by Type (2021-2032)
- 6.1.1 Global Diclazuril Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Diclazuril Sales Market Share by Type (2021-2032)
- 6.2 Global Diclazuril Revenue by Type (2021-2032)
- 6.2.1 Global Diclazuril Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diclazuril Revenue Market Share by Type (2021-2032)
- 6.3 Global Diclazuril Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diclazuril Sales by Application (2021-2032)
- 7.1.1 Global Diclazuril Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Diclazuril Sales Market Share by Application (2021-2032)
- 7.2 Global Diclazuril Revenue by Application (2021-2032)
- 7.2.1 Global Diclazuril Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diclazuril Revenue Market Share by Application (2021-2032)
- 7.3 Global Diclazuril Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diclazuril Value Chain Analysis
- 8.1.1 Diclazuril Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diclazuril Production Mode & Process
- 8.2 Diclazuril Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diclazuril Distributors
- 8.2.3 Diclazuril Customers
9 Global Diclazuril Analyzing Market Dynamics
- 9.1 Diclazuril Industry Trends
- 9.2 Diclazuril Industry Drivers
- 9.3 Diclazuril Industry Opportunities and Challenges
- 9.4 Diclazuril Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst